JPMorgan says Corteva split announcement has not lowered company’s value

Corteva's announcement to split into a pure-play seed company (Spinco) and a crop chemical business (New Corteva), with the latter retaining legacy PFAS and DuPont pension liabilities, triggered an initial market selloff of over 9%. Despite this, JPMorgan upgraded Corteva to Overweight, arguing the stock is now undervalued following the decline. The bank believes the separation will unlock value, enabling Spinco to achieve multiple expansion due to lower leverage and a pure-play focus, while New Corteva's EBITDA is structured to independently manage its historical obligations without impacting Spinco's future cash flows.

Analysis

Corteva (CTVA) has announced a plan to separate into two publicly traded companies by the second half of 2026, a move that triggered a significant negative market response. The stock declined over 9% following the announcement, contributing to a total market value loss of approximately $7.5 billion since reports of the plan first emerged. The restructuring will create a pure-play seed company, provisionally named 'Spinco,' and a crop chemical business, 'New Corteva.' Critically, 'New Corteva' will retain all historical PFAS and DuPont pension liabilities, and is structured to be financially self-sufficient in managing these obligations without recourse to Spinco's cash flows, contingent on its EBITDA remaining above a specified level. Despite the sharp selloff, JPMorgan has upgraded the stock to Overweight with a maintained $70 price target, arguing the market has overreacted and left the shares undervalued. The bank's analysis suggests the separation will unlock value, estimating that the implied valuation for the seed business is around 13.5x EBITDA and the chemical business is at 6x EBITDA, both of which are noted as being well below peer-group multiples.

Key Decisions for Investors

• Investors should assess the contrarian opportunity presented by the divergence between the market's sharp selloff and JPMorgan's valuation-driven upgrade, which points to potential undervaluation.
• A sum-of-the-parts analysis is critical, as the bull case hinges on the thesis that the separated seed and chemical businesses will re-rate to higher multiples, closer to their respective pure-play peers.
• Monitor execution risk leading up to the 2026 separation and closely track the financial performance of the future 'New Corteva' to validate its capacity to manage legacy liabilities without impacting the de-levered 'Spinco'.